Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 17,000 shares at $95.13 ($1.6M) on 2022-02-15, disclosed to the SEC on 2022-02-17.
Open-market sale of $1.6M TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TXG | SELL | 2022-02-24 | $23K | — | Filing → |
| TXG | SELL | 2022-01-14 | $3.5M | — | Filing → |
| TXG | SELL | 2021-12-15 | $4.2M | — | Filing → |